標(biāo)題: Titlebook: Chondrosarcoma; Biology and Clinical Francis J. Hornicek Book 2021 Springer Nature Switzerland AG 2021 Cartilage.Chondrosarcoma.Extraskelet [打印本頁] 作者: VIRAL 時間: 2025-3-21 18:10
書目名稱Chondrosarcoma影響因子(影響力)
書目名稱Chondrosarcoma影響因子(影響力)學(xué)科排名
書目名稱Chondrosarcoma網(wǎng)絡(luò)公開度
書目名稱Chondrosarcoma網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Chondrosarcoma被引頻次
書目名稱Chondrosarcoma被引頻次學(xué)科排名
書目名稱Chondrosarcoma年度引用
書目名稱Chondrosarcoma年度引用學(xué)科排名
書目名稱Chondrosarcoma讀者反饋
書目名稱Chondrosarcoma讀者反饋學(xué)科排名
作者: Canyon 時間: 2025-3-22 00:10 作者: Inexorable 時間: 2025-3-22 02:10 作者: 小步走路 時間: 2025-3-22 06:31
Chondrosarcomas: Conventional and Secondaryus neoplasm in the correct clinical and radiographic context. Chondrosarcomas are classified as primary if they arise de novo from bone and secondary if they develop from the malignant transformation of a preexisting benign lesion. The most common primary histopathologic type is termed “conventional作者: badinage 時間: 2025-3-22 11:53
Primary Soft Tissue Chondrosarcomae tumors and share the name chondrosarcoma. Mesenchymal chondrosarcoma comes from chondroid progenitor cells but histologically appears as a small round blue cell tumor and, unlike classic chondrosarcoma, appears to be somewhat sensitive to systemic therapy. It can occur primarily in soft tissue or 作者: ULCER 時間: 2025-3-22 14:32
Chondrosarcoma of the Appendicular Skeletonunterpart. It can occur as a primary lesion de novo or arise from a preexisting benign cartilage lesion. Conventional chondrosarcoma classically arises from the medullary cavity and will grow outward. It is a tumor of adult patient populations, characterized by the production of hyaline cartilage by作者: ULCER 時間: 2025-3-22 20:59
Chondrosarcoma of the Handprogressive swelling. Radiographs can show lytic lesions with cortical destruction and an associated soft tissue mass. Treatment options are controversial, though it is reasonable to attempt function-sparing reconstruction with close monitoring in some patients.作者: Addictive 時間: 2025-3-22 22:43
Chondrosarcoma of the Clavicleincluding the clavicle. They are slow-growing and indolent tumors that are locally aggressive but rarely metastatic. Patients are usually incidentally diagnosed or present with an enlarging supraclavicular mass that is minimally painful. Radiographs can show lytic, sclerotic, or mixed bone lesions w作者: 籠子 時間: 2025-3-23 02:45 作者: rheumatology 時間: 2025-3-23 09:20
Systemic Therapy for Chondrosarcomainary teams in sarcoma referral centers. Surgery represents the most effective modality for localized chondrosarcoma. In the setting of recurrent or advanced disease, current systemic therapies are relatively effective in only few subtypes including mesenchymal and dedifferentiated chondrosarcoma. F作者: circumvent 時間: 2025-3-23 09:56 作者: 盤旋 時間: 2025-3-23 17:01
The Future of Chondrosarcoma Research and Treatmentrs, with conventional chondrosarcomas having a notably bleak prognosis due to their resistance to available therapies. Recent technologies such as next-generation sequencing (NGS) have captured the genomic complexity of chondrosarcoma biology, including their variations in DNA mutational profiles, e作者: 口訣 時間: 2025-3-23 18:23 作者: insincerity 時間: 2025-3-24 00:51
Radiation Therapy for Chondrosarcomashould be considered for particle-based therapies (proton or carbon ion) when possible. Photon-based therapies should be delivered using advanced image guidance and intensity-modulated radiotherapy. For smaller tumors in the skull base, stereotactic radiosurgery should be considered. Radiation thera作者: 影響 時間: 2025-3-24 05:29 作者: orthopedist 時間: 2025-3-24 07:00
amines the future of chondrosarcoma management and development of novel adjuvant therapies, as well as the relationship of this disease to similar types (e.g., chordoma)...?Bringing together the most up-to-date978-3-030-74571-4978-3-030-74572-1作者: panorama 時間: 2025-3-24 12:41
https://doi.org/10.1007/978-3-322-96454-0 and radiation, although rare histologies and inoperable sites will still be treated with these modalities. Notable controversies persist in the surgical treatment of low-grade chondrosarcoma, in the feasibility of limb salvage in the setting of pathologic fracture, and in the management of chondros作者: 并置 時間: 2025-3-24 14:51 作者: Arbitrary 時間: 2025-3-24 19:00
Rechnungswesen, Controlling, Bankrechnenperately needed, and future clinical management will likely be informed by an improved understanding of subtype-specific pathways to aid in combination therapy selection. In this chapter, we discuss the future of chondrosarcoma research and summarize ongoing clinical trials evaluating novel approach作者: 繁榮地區(qū) 時間: 2025-3-24 23:23 作者: SLAY 時間: 2025-3-25 06:42 作者: hematuria 時間: 2025-3-25 08:13
https://doi.org/10.1007/978-3-662-00403-6ummarize the emerging works on CS biology, focusing on both genomic and epigenomic mechanisms and targets. These studies highlight several valuable clinical opportunities for earlier detection, prognostic accuracy, and therapeutic targeting that may?potentially improve patient outcomes.作者: 發(fā)酵 時間: 2025-3-25 14:12
Advances in the Molecular Biology of Chondrosarcomaummarize the emerging works on CS biology, focusing on both genomic and epigenomic mechanisms and targets. These studies highlight several valuable clinical opportunities for earlier detection, prognostic accuracy, and therapeutic targeting that may?potentially improve patient outcomes.作者: 喊叫 時間: 2025-3-25 17:12 作者: Lacerate 時間: 2025-3-25 19:58 作者: 邊緣 時間: 2025-3-26 01:46
Wolfgang Johannsen,Gerold Blakowskid distant recurrence, maintains a good survivorship prognosis. Unlike most soft tissue sarcomas or primary chondrosarcoma, it has documented responsiveness to both anthracycline-based chemotherapy and immunotherapy. The literature is mixed regarding response to radiation.作者: 上下倒置 時間: 2025-3-26 06:36 作者: optional 時間: 2025-3-26 10:14
Wolfgang Grundmann,Rudolf Rathner A variety of different surgical approaches can be made to facilitate safe, complete tumor resection and orthopedic and vascular reconstruction as needed. Postoperative care following these complex reconstructions should also be done in a multidisciplinary fashion to optimize outcomes.作者: 嚙齒動物 時間: 2025-3-26 15:35
Primary Soft Tissue Chondrosarcomad distant recurrence, maintains a good survivorship prognosis. Unlike most soft tissue sarcomas or primary chondrosarcoma, it has documented responsiveness to both anthracycline-based chemotherapy and immunotherapy. The literature is mixed regarding response to radiation.作者: antenna 時間: 2025-3-26 20:09 作者: Asseverate 時間: 2025-3-26 21:43
Vascular Issues in Complex Surgical Resection of Chondrosarcoma A variety of different surgical approaches can be made to facilitate safe, complete tumor resection and orthopedic and vascular reconstruction as needed. Postoperative care following these complex reconstructions should also be done in a multidisciplinary fashion to optimize outcomes.作者: 排名真古怪 時間: 2025-3-27 03:59 作者: 駕駛 時間: 2025-3-27 06:02 作者: mucous-membrane 時間: 2025-3-27 11:50
Wolfgang Grundmann,Rudolf Rathnerdvanced disease, current systemic therapies are relatively effective in only few subtypes including mesenchymal and dedifferentiated chondrosarcoma. Further research into the pathophysiology and genetic drivers of this disease will inform about future drug development for advanced stage chondrosarcoma.作者: 有惡意 時間: 2025-3-27 16:27 作者: Intruder 時間: 2025-3-27 19:39 作者: beta-cells 時間: 2025-3-28 01:17 作者: 時間等 時間: 2025-3-28 03:24
978-3-030-74571-4Springer Nature Switzerland AG 2021作者: 建筑師 時間: 2025-3-28 06:51 作者: FLING 時間: 2025-3-28 10:28 作者: byline 時間: 2025-3-28 17:17 作者: 支柱 時間: 2025-3-28 18:51
http://image.papertrans.cn/c/image/226174.jpg作者: FATAL 時間: 2025-3-29 00:12 作者: 剝皮 時間: 2025-3-29 05:32
https://doi.org/10.1007/978-3-662-00403-6teosarcoma. As CS is refractory to available chemotherapy and radiotherapy, aggressive surgical resection with wide margins remains the only effective treatment option. Cancer immunotherapies and targeted therapies have failed in clinical trials, and no prognostic biomarkers exist within the clinic.作者: decipher 時間: 2025-3-29 09:55 作者: Ingest 時間: 2025-3-29 12:25 作者: cartilage 時間: 2025-3-29 16:51
Wolfgang Johannsen,Gerold Blakowskie tumors and share the name chondrosarcoma. Mesenchymal chondrosarcoma comes from chondroid progenitor cells but histologically appears as a small round blue cell tumor and, unlike classic chondrosarcoma, appears to be somewhat sensitive to systemic therapy. It can occur primarily in soft tissue or 作者: Gingivitis 時間: 2025-3-29 19:47 作者: 以煙熏消毒 時間: 2025-3-30 00:13 作者: vocation 時間: 2025-3-30 06:11
Wolfgang Grundmann,Rudolf Rathnerincluding the clavicle. They are slow-growing and indolent tumors that are locally aggressive but rarely metastatic. Patients are usually incidentally diagnosed or present with an enlarging supraclavicular mass that is minimally painful. Radiographs can show lytic, sclerotic, or mixed bone lesions w
